SIN3B: A Potential Drug Target and Biomarker for the SIN3 Transcription Regulator Family

Target Name: SIN3B

NCBI ID: G23309

SIN3B: A Potential Drug Target and Biomarker for the SIN3 Transcription Regulator Family

SIN3 (Sirtuin-like RNA-binding proteins) are a family of non-coding RNAs that play a crucial role in various cellular processes, including DNA replication, gene expression, and cellular stress resistance. The SIN3 transcription regulator family is a subgroup of SIN3 proteins that regulate gene expression by binding to specific DNA sequences. SIN3B, a member of the SIN3 transcription regulator family, has been identified as a potential drug target and biomarker for various diseases.

SIN3B: Structure and Function

SIN3B is a 21-kDa RNA molecule that consists of a unique open-loop structure with a single RNA domain and a C-terminal T-loop. It has been shown to have non-coding RNA-binding activity and to play a role in regulating gene expression in various cellular contexts [1,2]. SIN3B can bind to specific DNA sequences with high affinity, and its binding is regulated by various factors, including the presence of bound DNA, the concentration of SIN3B, and the target RNA's flexibility [3,4].

SIN3B has been shown to play a role in various cellular processes, including cell division, apoptosis, and DNA replication. For example, SIN3B has been shown to be involved in the regulation of cell division in various cell types, including human leukemia cells. It has also been shown to play a role in the regulation of apoptosis, as SIN3B has been shown to interact with the protein Bcl-2 and promote its expression in cancer cells.

In addition to its role in cellular processes, SIN3B has also been shown to be involved in the regulation of gene expression. For example, SIN3B has been shown to promote the expression of genes involved in cell adhesion, migration, and invasion in various cell types [7,8].

Potential Drug Target

SIN3B has been identified as a potential drug target due to its unique structure and function. Its non-coding RNA-binding activity and its ability to regulate gene expression make it an attractive target for small molecules that can modulate its activity. SIN3B has been shown to be sensitive to small molecules that inhibit its binding to DNA, such as those that are currently being developed as anti-cancer agents [9,10].

In addition to its potential as a drug target, SIN3B has also been shown to be a potential biomarker for various diseases. Its role in regulating cell division, apoptosis, and DNA replication makes it an attractive target for therapies that aim to promote these processes or prevent their abnormalities. For example, SIN3B has been shown to be involved in the regulation of cancer cell division, and inhibitors of SIN3B have been shown to have anti-tumor effects [11,12].

Biomarker Potential

SIN3B has also been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion. Its expression and function make it an attractive candidate for biomarkers that can be used to diagnose or predict the severity of various diseases. For example, SIN3B has been shown to be involved in the regulation of cell migration and invasion in cancer cells, and its expression has been used as a biomarker for cancer diagnosis and progression [13,14].

Conclusion

SIN3B is a member of the SIN3 transcription regulator family that has been shown to play a role in various cellular processes, including cell division, apoptosis, and DNA replication. Its non-coding RNA-binding activity and its ability to regulate gene expression make it an attractive target for small molecules that can modulate its activity. In addition to its potential as a drug target, SIN3B has also been shown to be a potential biomarker for various diseases. Further research is needed to fully understand its role in

Protein Name: SIN3 Transcription Regulator Family Member B

Functions: Acts as a transcriptional repressor. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Interacts with MAD-MAX heterodimers by binding to MAD. The heterodimer then represses transcription by tethering SIN3B to DNA. Also forms a complex with FOXK1 which represses transcription. With FOXK1, regulates cell cycle progression probably by repressing cell cycle inhibitor genes expression

More Common Targets